FDA Commissioner Marty Makary has committed to reviewing the abortion pill’s safety, according to Sen. Josh Hawley (R-MO).
Hawley posted a letter he received from Makary on social media, noting the FDA head promised to review the safety of mifepristone, the popular abortion drug.
“As the Commissioner of Food and Drugs, I am committed to conducting a review of mifepristone and working with the professional career scientists at the Agency who review this data,” Makary wrote in his letter to Hawley.
“As with all drugs, FDA continues to closely monitor the postmarketing safety data on mifepristone for the medical termination of early pregnancy,” Makary wrote.
Makary also noted that mifepristone is currently enmeshed in legal battles.
“FDA generally does not comment on matters that are the subject of pending litigation and therefore is unable to provide further information on this topic at this time,” the FDA chief said.
Click this link for the original source of this article.
Author: Dillon B
This content is courtesy of, and owned and copyrighted by, https://www.offthepress.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.
